Towards recombinant antibody-fragment targeted photodynamic therapy

Science Progress

Volumn 91, Issue 3, 2008, Pages 241-263

  Milgrom, Lionel R ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Cancer targeting; Monoclonal antibody fragments; Photodynamic therapy; Photosensitisers

Indexed keywords

EID: 53949122436     PISSN: 00368504     EISSN: None     Source Type: Journal    
DOI: 10.3184/003685008X361415     Document Type: Review

References (42)

1. Dolmans, D. E., Fukumura, D. and Jain, R. K. (2003) Photodynamic therapy for cancer. Nat. Rev. Cancer, 3, 380-387.
2. Bonnett, R. (2000) Chemical aspects of photodynamic therapy, Gordon and Breach Science Publishers, Amsterdam.
3. Milgrom, L. R. (1997) The colours of life, pp. 207-214. University Press, Oxford.
4. Lou, P. J., Jones, L. and Hopper, C. (2003) Clinical outcomes of photodynamic therapy for head-and-neck cancer. Technol. Cancer Res. Treat., 2, 311-317.
5. Sickenberg, M. (2001) Verteporfin therapy for subfoveal choroidal neovascularization in age-related macular degeneration, from clinical trials to clinical practice. Semin. Ophthalmol., 16, 207-12.
6. Hamblin, M. R. and Hasan, T. (2004) Photodynamic Therapy, a new antimicrobial approach to infectious disease? Photochem. Photobiol. Sci., 3, 436-450.
7. Embleton, M. L., Nair, S. P., Cookson, B. D. and Wilson, M. (2004) Antibody-directed photodynamic therapy of methicillin resistant Staphylococcus aureus. Microb. Drug Resist., 10, 92-97.
8. Solban, N., Rizvi, I. and Hasan, T (2006) Targeted photodynamic therapy. Lasers Surg. Med., 38, 522-531.
9. Pervaiz, S. (2001) Reactive oxygen-dependent production of novel photochemotherapeutic agents. FASEB J., 15, 612-617.
10. Cox, J. P. L., Jankowski, K. J., Katzky, R., Parker, D., Beeley, N. R. A., Harrison, A. and Walker, C. (1989) Chem Commun., 797.
11. Jiang, F. N., Jiang, S., Liu, D. J., Richter, A. and Levy, J. G. (1990) J. Immun. Meth., 134, 139.
12. Jiang, F. N., Liu, D., Neyndorff, H., Chester, M., Jiang, S. and Levy, J. G. (1991) J. Natl. Cancer Inst., 83, 1218.
13. Egorov, Yu. S., Krasnovskii, A. A. Jr., Papkovskii, D. B., Ponomarev, G. V. and Savitskii, A. P. (1990) Bull. Exp. Biol. Med., 109, 454.
14. Milgrom, L. R. and O'Neill, F. (1995) Towards synthetic-porphyin/ monoclonal antibody conjugates. Tetrahedron, 51, 2137-2144.
15. Brand, F. X., Ravanel, N., Gauchez, A. S., Pasquier, D., Payan, R., Fagret, D. and Mousseau, M. (2006) Prospect for anti-HER2 receptor therapy in breast cancer. Anticancer Res., 26, 463-470.
16. van Dongen, G. A., Visser, G. W. and Vrouenraets, M. B. (2004) Photosensitizer-antibody conjugates for detection and therapy of cancer, Adv. Drug Deliv. Rev., 56, 31-52.
17. Molpus, K. L., Hamblin, M. R., Rizvi, I. and Hasan, T. (2000) Intraperitoneal photoimmunotherapy of ovarian carcinoma xenografts in nude mice using charged photoimmunoconjugates. Gynecol. Oncol., 76, 397-404.
18. Vrouenraets, M. B., Visser, G. W., Stewart, F. A., Stigter, M., Oppelaar, H., Postmus, P. E., Snow, G. B. and van Dongen, G. A. (1999) Development of meta-tetmhydroxyphenylchlorin-monoclonal antibody conjugates for photoimmunotherapy. Cancer Res., 59, 1505-1513.
19. Dougherty, T J. (1993) Photodynamic therapy. Photochem. Photobiol., 58, 895-900.
20. Embleton, M. L., Nair, S. P., Cookson, B. D. and Wilson, M. (2004) Antibody-directed photodynamic therapy of methicillin resistant Staphylococcus aureus. Microb. Drug Resist., 10, 92-97.
21. Savellano, M. D. and Hasan, T. (2003) Targeting cells that over-express the epidermal growth factor receptor with polyethylene glycolated BPD verteporfin photosensitiser immunoconjugates. Photochem. Photobiol., 77, 431-439.
22. Hudson, R., Carcenac, M., Smith, K., Madden, L., Clarke, O. J., Pelegrin, A., Greenman, J. and Boyle, R.W. (2005) The development and characterisation of porphyrin isothiocyanate- monoclonal antibody conjugates for photoimmunotherapy. Br. J. Cancer, 92, 1442-1449.
23. Vrouenraets, M. B., Visser, G. W., Loup, C., Meunier, B., Stigter, M., Oppelaar, H., Stewart, F. A., Snow, G. B. and van Dongen, G. A. (2000) Targeting of a hydrophilic photosensitiser by use of internalizing monoclonal antibodies, A new possibility for use in photodynamic therapy. Int. J. Cancer, 88, 108-114.
24. Aveline, B. M., Hasan, T. and Redmond, R. W. (1995) The effects of aggregation, protein binding and cellular incorporation on the photophysical properties of benzoporphyrin derivative monoacid ring A (BPDMA). J. Photochem. Photobiol., B, 30, 161-169.
25. Kuimova, M. K., Bhatti, M., Deonarain, M. P., Yahioglu, G., Levitt, J. A., Stamati, I., Suhling, K. and Phillips, D. (2007) Fluorescence characterisation of multiply-loaded anti-HER2 single-chain Fv-photosensitiser conjugates suitable for photodynamic therapy. Photochem. Photobiol. Sci., 6, 933-939.
26. Bhatti, M., Yahioglu, G., Milgrom, I. R., Garcia-Maya, M., Chester, K. A. and Deonarain, M. P. (2008) Targeted photodynamic therapy with multiply loaded recombinant antibody fragments. Int. J. Cancer, 122, 1155-1163.
27. Adams, G. P., Schier, R., Marshall, K., Wolf, E. J., McCall, A. M., Marks, J. D. and Weiner, L. M. (1999) Increased affinity leads to improved selective tumour delivery of single-chain Fv antibodies. Cancer Res., 58, 485-490.
28. Hendriks, B. S., Opresko, L. K., Wiley, H. S. and Lauffenburger, D. (2003) Quantitative analysis of HER2-mediated effects on HER2 and epidermal growth factor receptor endocytosis, distribution of homo-and heterodimers depends on relative HER2 levels. J. Biol. Chem., 278, 23343-23351.
29. Savellano, M. D., Pogue, B. W., Hoopes, P. J., Vitetta, E. S. and Paulsen, K. D. (2005) Multiepitope HER2 targeting enhances photoimmunotherapy of HER2-overexpressing cancer cells with pyropheophorbide-a immunoconjugates. Cancer Res., 65, 6371-6379.
30. Khurana, M., Collins, H. A., Karotki, A., Anderson, H. L., Cramb, D. T. and Wilson, B. C. (2007) Quantitative in vitro demonstration of two-photon photodynamic therapy using Photoffin® and Visudyne®. Photochem. Photobiol., 83, 1441-1448.
31. Batra, S. K., Jain, M., Wittel, U. A., Chauhan, S. C. and Colcher, D. (2002) Pharmacokinetics and biodistribution of genetically engineered antibodies. Curr. Opin. Biotechnol., 13, 603-608.
32. Chester, K. A., Bhatia, J., Boxer, G., Cooke, S. P., Flynn, A. A., Huhalov, A., Mayer, A., Pedley, R. B., Robson, L., Sharma, S. K., Spencer, D. I. and Begent, R. H. (2000) Clinical applications of phage-derived sc-Fvs and sc-Fv fusion proteins. Dis. Markers, 16, 53-62.
33. Birchler, M., Viti, F., Zardi, L., Spiess, B. and Neri, D. (1999) Selective targeting and photocoagulation of ocular angiogenesis mediated by a phage-derived human antibody fragment. Nat. Biotechnol., 17, 984-988.
34. Fabbrini, M., Trachsel, E., Soldani, P., Bindi, S., Alessi, P., Bmcci, L., Kosmehl, H., Zardi, L., Neri, D. and Neri, P. (2006) Selective occlusion of tumour blood vessels by targeted delivery of an anti-bodyphotosensitiser conjugate. Int. J. Cancer, 118, 1805-1823.
35. Begent, R. H., Verhaar, M. I., Chester, K. A., Casey, J. L., Green, A. J., Napier, M. P., Hope-Stone, L. D., Cushen, N., Keep, P. A., Johnson, C. J., Hawkins, R. E., Hilson, A. J. and Robson, L. (1996) Clinical evidence of efficient tumour targeting based on single-chain Fv antibody selected from a combinatorial library. Nat. Med., 2, 979-984.
36. Adams, G. P., Schier, R., Marshall, K., Wolf, E. I., McCall, A. M., Marks, J. D. and Weiner, L. M. (1999) Increased affinity leads to improved selective tumour delivery of single-chain Fv antibodies. Cancer Res., 58, 485-490.
37. Haddad, R., Kaplan, O., Greenberg, R., Siegal, A., Skomick, Y. and Kashtan, H. (2000) Photodynamic therapy of murine colon cancer and melanoma using systemic aminolevulinic acid as a photosensitiser. Int. J. Surg. Investig., 2, 171-178.
38. Cuenca, R. E., Allison, R. R., Sibata, C. and Downie, G. H. (2004) Breast cancer with chest wall progression, treatment with photodynamic therapy. Ann. Surg. Oncol., 11, 322-327.
39. Muschter, R. (2003) Photodynamic therapy, a new approach to prostate cancer. Curr. Urol. Rep., 4, 221-228.
40. Hackbarth, S., Horneffer, V., Wiehe, A., Hillenkamp, F. and Roder, B. (2001) Photophysical properties of pheophorbide-a substituted with a diamonobutanepolypropylene-imine dendrimer. Chem. Phys., 269, 339-346.
41. Renard, M., Belkadi, L. and Bedouelle, H. (2003) Deriving topological constraints from functional data for the design of reagent-less fluorescent immunosensors. J. Mol. Biol., 326, 167-175.
42. Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R. and Langer, R. (2007) Nature Nanotechnol., 2, 751-760.